BGJ398
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for BGJ398, covering 2015-02-16 to 2024-03-05. Get the full timeline:
Most recent: Clinical Trial Update: LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF Melanoma [Phase 2]